All News

As young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery, researchers wanted to develop gentler treatment options.

Selinexor (Xpovio, Karyopharm) tablets in combination with the corticosteroid dexamethasone was approved under the agency's accelerated approval program.

Selinexor (Xpovio, Karyopharm) received approval in combination with dexamethasone for heavily-pretreated patients with relapsed or refractory multiple myeloma.

Three new studies looked at the mechanisms involved in tissue damage related to rheumatoid arthritis and lupus.

FOXA1 has been previously known to be mutated in prostate cancer; however, its biological functions were not understood well.

One company, LogicStream Health, creates software that integrates with a hospital EHR system for multiple platform services.

Top news of the day from across the health care landscape.

Health care professionals, including pharmacists and nurse practitioners, play a critical role in attaining goals for reducing HIV transmission.

Drug shortages can adversely affect patient care in the community and hospital settings.

Aptevo Therapeutics announced the launch of its new vial size for its coagulation factor IX recombinant (Ixinity) treatment for hemophilia B in the US market.

A recent study showed that adherence to prophylaxis for severe hemophilia A can improve a patient’s physical performance.

Top news of the day from across the health care landscape.

Water safety is important, especially with summertime here, but it is crucial for parents to remain vigilant all year round.

Medi-Dose® has created bright yellow Lid-Label® Covers for use with our Circular and Oval Medi-Cup® Blisters.

Camille Schrier, a PharmD student at the VCU School of Pharmacy, used a fun science experiment to showcase her talent during the Miss Virginia pageant.

Specific types of cancer—such as bone, kidney, throat, and uterine—also had a higher incidence of chronic and severe pain that restricted daily activity.

What is causing excessive bruising in a patient?

Treatment with secukinumab (Cosentyx, Novartis) inhibited radiographic progression in most patients with psoriatic arthritis over 2 years in a phase 3 trial.

Top news of the day from across the health care landscape.

The 21-week 2018-2019 influenza season was the longest in 10 years.

Bruce Kneeland, community pharmacy consultant, discusses how community pharmacists can counsel and manage travel vaccinations at their pharmacies, in an interview with Pharmacy Times.

Retrophin's enteric-coated formulation allows administration with or without food.

Officials with the FDA have approved a new enteric-coated formulation of tiopronin (Thiola EC, Retrophin) 100 mg and 300 mg tablets, for the treatment of cystinuria.

This funding is part of an effort to provide technical assistance to enhance efforts to end the HIV epidemic.

Technology solutions such as CourMed will allow better pharmacist-patient communication, adherence, and overall improved patient outcomes.

Pharmacists are taking to social media in response to layoffs at Walmart pharmacies across the country.

Pfizer’s bevacizumab-bvzr (Zirabev) demonstrated clinical equivalence and no clinically meaningful differences compared with the reference product.

Pfizer’s bevacizumab-bvzr (Zirabev) demonstrated clinical equivalence and no clinically meaningful differences compared with the reference product.

Fewer than 40% of people have ever had a HIV test, and less than 30% of people in the United States most at risk of acquiring HIV were tested in the past year.

First-line treatment with dabrafenib (Tafinlar) plus trametinib (Mekinist) demonstrated overall and progression-free long-term survival benefits in patients with BRAF-mutation positive melanoma.